Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
Saved in:
| Title: | Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo. |
|---|---|
| Authors: | Qian K; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Tang CY; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Changxing People's Hospital of Zhejiang, Huzhou 313100, China., Chen LY; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Zheng S; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Zhao Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Ma LS; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Xu L; The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China., Fan LH; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Yu JD; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Tan HS; Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Sun YL; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Shen LL; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Lu Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Liu Q; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States., Liu Y; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill 27599, North Carolina, United States., Xiong Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China. |
| Source: | ACS omega [ACS Omega] 2021 Apr 13; Vol. 6 (16), pp. 10645-10654. Date of Electronic Publication: 2021 Apr 13 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101691658 Publication Model: eCollection Cited Medium: Internet ISSN: 2470-1343 (Electronic) Linking ISSN: 24701343 NLM ISO Abbreviation: ACS Omega Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
